Synta Announces FDA's Oncologic Drugs Advisory Committee to Discuss Pediatric Uses for Ganetespib

Synta Pharmaceuticals Corp. (NASDAQ: SNTA) today announced that the Company has been invited by the U.S. Food and Drug Administration ...